(a and c) Daily means (±SEM) of (a) MWT sleep onset latency and (c) PVT performance in the sleep restriction group (n = 142, 4 h TIB for five nights [SR1–SR5], solid line), and the control group (n = 17, 10 h TIB on all nights, dashed line). All subjects had 10 h TIB (22:00–08:00) on baseline day 2 (B2). Sleep restriction on SR1 to SR5 was from 04:00 to 08:00. Data are plotted to show deficits in neurobehavioral functions increasing (upward) on the ordinate. Relative to the control condition, sleep restriction degraded neurobehavioral function over days (decreased MWT sleep onset latency and increased PVT lapses [>500 ms reaction times]). (b and d) Daily means (±SEM) of (b) MWT sleep onset latency and (d) PVT performance following the acute recovery (REC) night as a function of increasing TIB dose (0–10 h, solid line), controlling for covariates (i.e., baseline, cumulative deficits during sleep restriction, age, and sex). Sleep-restricted subjects (n = 142) were randomized to either 0 h TIB (n = 13), 2 h TIB (n = 27), 4 h TIB (n = 29), 6 h TIB (n = 25), 8 h TIB (n = 21), or 10 h TIB (n = 27). For comparison, horizontal dotted lines show baseline night (B2, 10 h TIB) values, and horizontal dashed lines show control group (n = 17) means on day 8 (10 h TIB), which is the study day equivalent to REC. These neurobehavioral outcomes showed improvement as recovery sleep doses increased (MWT sleep onset latencies increased and PVT lapses decreased); however, even at the highest sleep recovery dose, functioning did not return to baseline or control condition levels. (Reprinted with permission from Banks et al., 2010.)